Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFAstraZenecaNot Yet RecruitingPhase 3
NCT07761117Not Yet Recruiting
Phase 3
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Ad...AstraZeneca
NCT07761572
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific ABNot Yet RecruitingPhase 2
NCT07761572Not Yet Recruiting
Phase 2
CS1 Added to Standard of Care Therapy for Pulmonary Arterial HypertensionCereno Scientific AB
NCT07759843
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo UniversityRecruiting
NCT07759843Recruiting
—
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo University
NCT07760675
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Caring for 2 Spirit Metis Patients Using and AI Assisted OSCE.Canadian Institutes of Health Research (CIHR)Not Yet RecruitingNot Applicable
NCT07760675Not Yet Recruiting
Not Applicable
Evaluating in Person Curriculum for Educating Obstetrical Residents on Better Ca...Canadian Institutes of He...
NCT07759479
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Duration in Primiparous WomenIstanbul UniversityCompletedNot Applicable
NCT07759479Completed
Not Applicable
Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Dura...Istanbul University
NCT07761559
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness and Consumption Among University StudentsBENGİSU KARAGÖZActive Not RecruitingNot Applicable
NCT07761559Active Not Recruiting
Not Applicable
Effect of a Nutrition Education Intervention on Ultra-Processed Food Awareness a...BENGİSU KARAGÖZ
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07760246
A Study in Healthy People to Measure How Different Doses of Verducatib Affect the HeartBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07760246Not Yet Recruiting
Phase 1
A Study in Healthy People to Measure How Different Doses of Verducatib Affect th...Boehringer Ingelheim
NCT07760623
Common Carotid Artery-Renal Artery-Femoral Artery Survey for HypertensionDejthidaNathaphongNot Yet Recruiting
NCT07760623Not Yet Recruiting
—
Common Carotid Artery-Renal Artery-Femoral Artery Survey for HypertensionDejthidaNathaphong
NCT07759622
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcare Provider Trust Using Evidence Informed RecommendationsLund UniversityRecruitingNot Applicable
NCT07759622Recruiting
Not Applicable
The Cesarean Study: Optimizing Cesarean Sections and Improving Patient-Healthcar...Lund University
NCT07761052
The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scale a Culturally-Adapted and Evidence-Based Intervention for Latino FamiliesNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07761052Not Yet Recruiting
Not Applicable
The Latino Youth and Family Empowerment Study - III (LYFE-III): Bringing to Scal...National Institute of Men...
NCT07761793
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman AlghoulNot Yet RecruitingNot Applicable
NCT07761793Not Yet Recruiting
Not Applicable
Diaphragmatic Myofascial Release Added to Neck Exercises for Chronic Neck PainAbdelrahman Alghoul
NCT07759492
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung CancerIntergroupe Francophone de Cancerologie ThoraciqueNot Yet RecruitingPhase 2
NCT07759492Not Yet Recruiting
Phase 2
Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cance...Intergroupe Francophone d...
NCT07761845
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of Patients With Burn InjuriesAin Shams UniversityRecruiting
NCT07761845Recruiting
—
Red Cell Distribution Width/Albumin Ratio as a Predictive Tool for Mortality of...Ain Shams University
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary SyndromeMst.Sumyara KhatunCompletedNot Applicable
NCT07759518Completed
Not Applicable
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian St...Mst.Sumyara Khatun
NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)Eli Lilly and CompanyNot Yet RecruitingPhase 2
NCT07759245Not Yet Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe...Eli Lilly and Company
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07759882
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)University of ArkansasNot Yet RecruitingNot Applicable
NCT07759882Not Yet Recruiting
Not Applicable
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care Settin...University of Arkansas
NCT07760467
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TUL321 Capsules in Healthy Participants.Zhuhai United Laboratories Co., Ltd.Not Yet RecruitingPhase 1
NCT07760467Not Yet Recruiting
Phase 1
To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral TU...Zhuhai United Laboratorie...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed2 (10%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 12 (10%)
Phase 31 (5%)